Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Finished Goods (2016)

Historic Finished Goods for Avadel Pharmaceuticals (AVDL) over the last 3 years, with Q2 2016 value amounting to $3.3 million.

  • Avadel Pharmaceuticals' Finished Goods changed N/A to $3.3 million in Q2 2016 from the same period last year, while for Jun 2016 it was $3.3 million, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2015, which is N/A changed from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Finished Goods stood at $3.3 million for Q2 2016.
  • Avadel Pharmaceuticals' 5-year Finished Goods high stood at $3.3 million for Q2 2016, and its period low was $2.5 million during Q4 2015.